Home › Atopic Dermatitis (Eczema) › New York › New York City
Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa New York City, NY
Isang pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- OptiSkin Medical, New York
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Enveda Investigative Site, New York
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Nagre-recruitPhase 2
- Investigational Site, New York
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Nagre-recruit
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Sadick Research Group, LLC, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Inmagene Site 21, New York
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Nagre-recruitPhase 3
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Nagre-recruitPhase 1
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- Sadick Research Group, New York
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Nagre-recruitObservasyonal na pag-aaral
- Galderma Investigational Site - 7051, New York
- Galderma Investigational Site 7109, New York
- Galderma Investigational Site 8279, New York
Allergy and Immunology Natural History Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Nagre-recruitPhase 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Pfizer, New York
Pag-aaral para sa Atopic Dermatitis (Eczema) sa ibang lungsod
- Los Angeles, CA11 pag-aaral
- Washington, DC11 pag-aaral
- San Antonio, TX10 pag-aaral
- San Diego, CA10 pag-aaral
- Birmingham, AL9 pag-aaral
- Miami, FL9 pag-aaral
- Dallas, TX8 pag-aaral
- Huntington Beach, CA8 pag-aaral
- Sacramento, CA8 pag-aaral
- Troy, MI8 pag-aaral
- Indianapolis, IN7 pag-aaral
- Tampa, FL7 pag-aaral
Iba pang pag-aaral sa New York City
- Kanser sa Suso136 pag-aaral
- Non-Small Cell Lung Cancer121 pag-aaral
- Kanser (lahat ng uri)109 pag-aaral
- Kanser sa Prostate103 pag-aaral
- Metastatic Cancer93 pag-aaral
- Colorectal Cancer78 pag-aaral
- Kanser sa Ovary69 pag-aaral
- Kanser sa Baga60 pag-aaral
- Multiple Myeloma60 pag-aaral
- Kanser sa Pancreas60 pag-aaral
- Kanser ng Endometrium52 pag-aaral
- Acute Myeloid Leukemia51 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.